Merry AF, Mitcell SJ. Complications of anaesthesia. Anaesthesia, 2018; 73: 7-11.
Veilleux-Lemieux D, Castel A, Carrier D, Beaudry F, Vachon P. Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats. Journal of the American Association for Laboratory Animal Science, 2013; 52: 567-570.
Dugassa J, Fromsa A. Review on dissociative anaesthetics and compatible drug combinations in veterinary clinical practice. Veterinary Medicine, 2018; 3: 21-30.
Davis JA. Mouse and rat anesthesia and analgesia. Current Protocols in Neurosciences 2008; 42: 1-21.
Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Experimental Biology and Medicine (Maywood), 2005; 230: 777-784.
Erfanparast A, Tamaddonfard E, Mohammadi E, Mohammadi A. Effect of vitamine B12 on acute model of hyperglycemia induced by ketamine xylazine in rats. Urmia Medical Journal, 2017; 28: 28-38.
Zhou H, Beevers CS, Huang S. The targets of curcumin. Current Drug Targets 2011; 12: 332-347.
Ghorbani Z, Hekmatdoost A, Mirmiran P. Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. International Journal Endocrinology and Metabolism, 2014; 12: e18081.
Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Scientific World Journal, 2009; 9: 1233-1241.
Röder PV, Wu B, Liu Y, Han W. Pancreatic regulation of glucose homeostasis. Experimental and Molecular Medicine, 2016; 48: e219.
Chandra R, Liddle RA. Modulation of pancreatic exocrine and endocrine secretion. Current Opinion in Gastroenterology, 2013; 29: 517-522.
Cabral AD, Kapusta DR, Kenigs VA, Varner KJ. Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. American Journal of Physiology, 1998; 275: 1867-1874.
Tamaddonfard E, Erfanparast A, Hamzeh-Gooshchi N, Yousofizadeh S. Effect of curcumin, the active constituent of turmeric, on penicillin-induced epileptiform activity in rats Avicenna Journal of Phytomedicine, 2012; 2: 196-205.
Moradi-Arzeloo M, Farshid AA, Tamaddonfard E, Asri-Rezaei S. Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Veterinary Research Forum, 2016; 7: 47-54.
Taati M, Tamaddonfard E. Ventrolateral orbital cortex oxytocin attenuates neuropathic pain through periaqueductal gray opioid receptor. Pharmacological Reports, 2018; 70: 577-583.
Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesthesia and Essays Research, 2014; 8: 283-290.
Tyler MW, Yourish HB, Ionescu DF, Haggarty SJ. Classics in chemical neuroscience: ketamine. ACS Chemical Neuroscience, 2017; 8: 1122-1134
Greene SA, Thurmon JC. Xylazine - a review of its pharmacology and use in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 1988; 11: 295-313.
Fagerholm V, Haaparanta M, Scheinin M. α2-adrenoceptor regulation of blood glucose homeostasis. Basic and Clinical Pharmacology and Toxicology, 2011; 108: 365-370.
Kitano T, Kobayashi T, Yamaguchi S, Otsuguro KI. The α2A -adrenoceptor subtype plays a key role in the analgesic and sedative effects of xylazine. Journal of Veterinary Pharmacology and Therapeutics, 2019; 42: 243-247.
Singh A, Gibert Y, Dwyer KM. The adenosine, adrenergic and opioid pathways in the regulation of insulin secretion, beta cell proliferation and regeneration. Pancreatology, 2018; 18: 615-623.
Restitutti F, Raekallio M, Vainionpää M, Kuusela E, Vainio O. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral α-2 adrenoceptor antagonist. Veterinary Journal, 2012; 193: 481-485.
Kato M, Nishikawa S, Ikehata A, Dochi K, Tani T, Takahashi T, Imaizumi A, Tsuda T. Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Molecular Nutrition & Food Research, 2017; 61: 3.
Abdel Aziz MT, El-Asmar MF, El Nadi EG, Wassef MA, Ahmed HH, Rashed LA, Obaia EM, Sabry D, Hassouna AA, Abdel Aziz AT. The effect of curcumin on insulin release in rat-isolated pancreatic islets. Angiology, 2010; 61: 557-566.
Parmar MS, Syed I, Gray JP, Ray SD. Curcumin, hesperidin, and rutin selectively interfere with apoptosis signaling and attenuate streptozotocin-induced oxidative Stress-mediated hyperglycemia. Current Neurovascular Research, 2015; 12: 363-374.
Meghana K, Sanjeev G, Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Euroupean Journal of Pharmacology, 2007; 577: 183-191.
Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, Li XX, Sun CH. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Molecular Nutrition & Food Research, 2013; 57: 1569-1577.
Dewar AM, Clark RA, Singer AJ, Frame MD. Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors. Journal of Investigative Dermatology, 2011; 131: 1754-1760.
Cheng TC, Lin CS, Hsu CC, Chen LJ, Cheng KC, Cheng JT. Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. Neuroscience Letter, 2009; 465: 238-241.
Boozari M, Butler AE, Sahebkar A. Impact of curcumin on toll-like receptors. Journal of Cellular Physiology, 2019; 234: 12471-12482.
Cheng YF, Guo L, Xie YS, Liu YS, Zhang J, Wu QW, Li JM. Curcumin rescues aging-related loss of hippocampal synapse input specificity of long term potentiation in mice. Neurochemical Research, 2013; 38: 98-107.